Biopharmaceutical company Odyssey Therapeutics (ODTX.O), opens new tab has raised $279 million in its upsized U.S. initial public offering, the company said on Thursday.
Seaport Therapeutics has raised about $255 million through an upsized initial public offering in the United States, marking a strong entry into public markets for the clinical-stage drug developer.
08 May 2026-05:35
01 May 2026-10:43
